BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Solvay Chemicals Inc. 

3333 Richmond Avenue

Houston  Texas  77098  U.S.A.
Phone: 713-525-6000 Fax: 713-525-7887


SEARCH JOBS


Industry
Big Pharma

Segment
Pharmaceuticals

Collaborations

Cadus Corporation  Focus on the development of drug discovery assays





 Company News
Solvay Chemicals Inc. to Invest $135 Million in Brazil Plant 12/14/2007 6:41:26 AM    More...
Solvay Chemicals Inc. to Sell Polypropelene Activities to Basell 11/29/2007 11:43:55 AM    More...
Solvay Chemicals Inc. Gets Promotion Rights for Abbott Laboratories (ABT)'s SIMCOR 10/22/2007 6:38:53 AM    More...
Solvay Chemicals Inc. Sells Caprolactones Unit for 200 Million Euros 10/15/2007 9:02:21 AM    More...
Solvay Chemicals Inc. Announces Three Major Appointments 7/16/2007 11:58:12 AM    More...
BioSouth, Inc. Release: Top Pharmaceutical Companies Seeking Partners At BioFusion 2006 8/31/2006 10:48:46 AM    More...
FDA Requests Further Data On Cilansetron, Solvay Pharmaceuticals, Inc.'s Proposed Treatment For Irritable Bowel Syndrome Wth Diarrhea Predominance (IBS-D) 10/19/2005 5:13:11 PM    More...
Solvay SA To Buy France's Fournier Pharma For 1.6 Billion Euros ($2.09 billion) 10/19/2005 5:13:06 PM    More...
AEterna Zentaris (AEZS) Announces Cetrorelix Development With Solvay Chemicals Inc. Continues With Endometriosis As A Primary Indication 10/19/2005 5:13:01 PM    More...
Solvay Pharmaceuticals, Inc. And CV Therapeutics, Inc. (CVTX) Release: Supplemental New Drug Application For ACEON(R) Label Expansion Based On EUROPA Outcomes Data Submitted To U.S. FDA 10/19/2005 5:12:28 PM    More...
12

//-->